EUVIMEDEUVIMED entdecken
Crossref

Stem Cell Treatment for Dilated Cardiomyopathy: A Review of Recent Scientific Advances

Liddy Kasraian, John Railey, Caitlin Mehta, Madeline H Garvey

Georgetown Medical Review · 2024

DOI: 10.52504/001c.123163 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Georgetown Medical Review, 2024. Verfasst von Liddy Kasraian und 3 weiteren Autor:innen. Die Arbeit nennt 24 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiomyopathy, a disorder of mechanical and electrical cardiac action, is a significant cause of morbidity and mortality in the United States and is seen in both adult and pediatric populations. Dilated cardiomyopathy, a subtype involving pathological enlargement of the heart, in particular causes significant reduction in quality of life and is a significant risk factor for heart failure development. Traditional treatment for dilated cardiomyopathy largely focuses on symptomatic relief and delayed progression of disease but does not offer a cure or reversal of disease process. In the past few decades, stem cell therapy has become a promising therapeutic because these cells can differentiate into human cardiomyocytes and offer a potential restoration of normal cardiomyocyte function. This review highlights 3 methodological derivations of cardiomyocytes: bone marrow–derived hematopoietic stem cells, mesenchymal stem cells, and adipose-derived stem cells. While most of the current research has focused on hematopoietic stem cells for dilated cardiomyopathy, further research is needed to elucidate which stem cell line is superior and most effective for disease treatment and reversal. This review highlights future directions of this line of research, such as direct comparison between cell types, analysis of the long-term effects of stem cell treatment, increased sample sizes, and potential use of this treatment in the pediatric and adult populations.

Zitieren

APA

Kasraian, L., Railey, J., Mehta, C., & Garvey, M. H. (2024). Stem Cell Treatment for Dilated Cardiomyopathy: A Review of Recent Scientific Advances. Georgetown Medical Review. https://doi.org/10.52504/001c.123163

Vancouver

Kasraian L, Railey J, Mehta C, Garvey MH. Stem Cell Treatment for Dilated Cardiomyopathy: A Review of Recent Scientific Advances. Georgetown Medical Review. 2024. doi:10.52504/001c.123163

BibTeX
@article{Kasraian2024,
  author = {Kasraian, Liddy and Railey, John and Mehta, Caitlin and Garvey, Madeline H},
  title = {Stem Cell Treatment for Dilated Cardiomyopathy: A Review of Recent Scientific Advances},
  journal = {Georgetown Medical Review},
  year = {2024},
  doi = {10.52504/001c.123163}
}
Kostenlos starten →